Certified by Founder Lodge 
                                        
                                        Ancilia Biosciences
 
                                                 United States  -  New York, New York 
                                             START UP 
                                                                                    1 Disclosed Funding Rounds $4,200,000
                                            0 Participating Investments
- 
                                                Founded date 
                                                
2019
 - 
                                                Operating Status 
                                                
Active
 - 
                                                Last Funding Type 
                                                
Seed
 - 
                                                Company Type 
                                                
For Profit
 - Website
 - Contact
 - Social Links
 
                                            Ancilia is harnessing the natural power of CRISPR to develop a new class of bacterial therapies and products for a range of applications.
                                        
                                        
                                        
                                                                                
                                        
                                                                                | Date | Round | Raised | Participating Investors | 
|---|---|---|---|
| August, 29 ,2024 | Unknown | $4,200,000 | 
                                                
 Metaplanet
                                                                                
                                                                            
 Safar Partners
                                                                                
 Spacecadet
                                                                                
 Zubi Capital
                                                                                
                                                                            
 PsyMed Ventures
                                                                                
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
                                                                        
                                Helex |  $3,500,000  | (Nov 4, 2025)
                                                                        
                                xMEMS |  $21,000,000  | (Nov 4, 2025)
                                                                        
                                catalyx space |  $5,400,000  | (Nov 4, 2025)
                                                                        
                                Cephia AI |  $4,000,000  | (Nov 4, 2025)
                                                                        
                                Ornn |  $5,700,000  | (Nov 4, 2025)